Robot aims to improve prostate cancer diagnosis
NCT ID NCT07271017
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests a new robot and ultrasound probe, called ProBot, designed to make prostate biopsies more precise and comfortable. The study will enroll 60 men with suspected prostate cancer to see if the device is safe and works as intended. If successful, it could lead to better detection of aggressive cancers while reducing unnecessary procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ProBot robot and novel ultrasound probe
- What this could lead to
- If successful, this could make prostate biopsies more accurate and less painful, improving cancer detection.
- What could go wrong
- This is a small, early-phase safety and feasibility study. The device may not work better than current methods, and unexpected complications could arise.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Hospital
RECRUITINGBaltimore, Maryland, 21287, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sharper eye on prostate cancer return: PSMA PET vs. MRI
- AI may help spot dangerous prostate cancer and spare men from needless biopsies
- Blood test may spot prostate cancer without a needle
- AI reads scans to spot prostate cancer, spare unnecessary biopsies
- Extra numbing shot may ease pain of prostate biopsy
- Community-Led push to catch prostate cancer early in black men